Clinical Trials in Portland

Showing 5641-5660 of 10,048 trials

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

NCT02553330

A phase 2 study to find out if the drug ruxolitinib Phosphate Cream is safe and has beneficial effects in people who have alopecia areata (partial or complete hair loss) when applied to the skin.

Alopecia Areata

Incyte Corporation90 participantsStarted Nov 2015

Birmingham, Alabama, United States • Hot Springs, Arkansas, United States • New Haven, Connecticut, United States +15 more locations

COMPLETEDPhase 2< 1 mile

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

NCT03495817

Open label study to assess safety, tolerability, and efficacy of ATI-50002 in male and female subjects with androgenetic alopecia.

Androgenetic Alopecia

Aclaris Therapeutics, Inc.31 participantsStarted Mar 2018

Denver, Colorado, United States • Portland, Oregon, United States • Austin, Texas, United States

COMPLETEDNA< 1 mile

Fluid Responsiveness Evaluation in Sepsis-associated Hypotension

NCT02837731

This study assesses the mean difference in fluid balance at ICU discharge and associated patient outcomes, based on a dynamic assessment of fluid responsiveness in septic patients with refractory hypotension in an ICU setting.

SepsisHypotension

Cheetah Medical Inc.150 participantsStarted Oct 2016

San Francisco, California, United States • Denver, Colorado, United States • Atlanta, Georgia, United States +9 more locations

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

Fluid Responsiveness Evaluation in Sepsis-associated Hypotension

Find Trials by Condition in Portland

Minocycline Pharmacokinetics (ACUMIN)

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

Evaluation of Biomarkers of Traumatic Brain Injury

A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)

Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children

The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Advance Care Planning Evaluation in Hospitalized Elderly Patients

Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration (FNA) With Rapid On-site Evaluation (ROSE) of Cytopathology vs. EUS-guided Fine Needle Biopsy (FNB) Alone in the Diagnosis of Pancreatic Solid Lesions

Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation

A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy

MRI Biomarkers in ALS